TG Therapeutics, Inc. SEC filings TGTX

TG Therapeutics, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Feb 28, 2003. Its latest annual report, Form 10-K, was filed on Feb 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 3, 2026 (results of operations). The company's fiscal year ends on December 31.

TG Therapeutics, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 27, 2026 —
4 Insider transaction Sep 14, 2026 Sep 10, 2026
144 Notice of proposed sale Sep 10, 2026 —
4 Insider transaction Aug 7, 2026 Aug 6, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 3, 2026 Aug 3, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 15, 2026 Jun 11, 2026
8-K Current report
Shareholder vote results
Jun 12, 2026 Jun 11, 2026
8-K Current report
Other events
Jun 3, 2026 Jun 3, 2026
8-K Current report
Other events
May 27, 2026 May 27, 2026
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 6, 2026 May 6, 2026
DEF 14A Proxy statement Apr 30, 2026 Jun 11, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
8-K Current report
Material agreement, New debt
Mar 20, 2026 Mar 18, 2026
10-K Annual report Feb 27, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
4 Insider transaction Jan 29, 2026 Jan 28, 2026
8-K Current report
Regulation FD disclosure
Jan 13, 2026 Jan 13, 2026
4 Insider transaction Jan 9, 2026 Jan 8, 2026
4 Insider transaction Jan 9, 2026 Jan 8, 2026
4 Insider transaction Nov 25, 2025 Nov 24, 2025
144 Notice of proposed sale Nov 24, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Nov 10, 2025 —
4 Insider transaction Nov 7, 2025 Nov 5, 2025
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 3, 2025 Nov 3, 2025
4 Insider transaction Sep 12, 2025 Sep 11, 2025
144 Notice of proposed sale Sep 11, 2025 —
S-8 Employee stock plan registration Aug 8, 2025 —
S-3ASR Automatic shelf registration Aug 8, 2025 —
10-Q Quarterly report Aug 8, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 4, 2025 Aug 4, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
8-K Current report
Shareholder vote results
Jun 13, 2025 Jun 12, 2025
144 Notice of proposed sale Jun 13, 2025 —
SCHEDULE 13G Ownership over 5% (passive) May 13, 2025 —
10-Q Quarterly report May 9, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 5, 2025 May 5, 2025
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 30, 2025 —
DEF 14A Proxy statement Apr 30, 2025 Jun 12, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 30, 2025 —
PRE 14A Preliminary proxy statement Apr 18, 2025 Jun 12, 2025
4 Insider transaction Mar 18, 2025 Mar 17, 2025
4 Insider transaction Mar 11, 2025 Mar 10, 2025
10-K Annual report Mar 3, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 3, 2025 Mar 3, 2025
4 Insider transaction Jan 30, 2025 Jan 29, 2025
4 Insider transaction Jan 30, 2025 Jan 29, 2025
8-K Current report
Regulation FD disclosure
Jan 14, 2025 Jan 14, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 8, 2025 —
4 Insider transaction Jan 7, 2025 Jan 3, 2025
144 Notice of proposed sale Jan 6, 2025 —
144 Notice of proposed sale Jan 3, 2025 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
4 Insider transaction Nov 12, 2024 Nov 11, 2024
4 Insider transaction Nov 12, 2024 Nov 11, 2024
144/A Filing Nov 12, 2024 —
144 Notice of proposed sale Nov 12, 2024 —
144 Notice of proposed sale Nov 12, 2024 —
4 Insider transaction Nov 7, 2024 Nov 5, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
144 Notice of proposed sale Nov 5, 2024 —
8-K Current report
Results of operations
Nov 4, 2024 Nov 4, 2024
SC 13G/A Amended ownership over 5% (passive) Oct 7, 2024 —
10-Q Quarterly report Aug 9, 2024 Jun 30, 2024
10-K/A Amended annual report Aug 9, 2024 Dec 31, 2023
8-K Current report
Material agreement, Agreement ended, Results of operations, Other events
Aug 6, 2024 Aug 2, 2024
4 Insider transaction Jun 20, 2024 Jun 17, 2024
4 Insider transaction Jun 20, 2024 Jun 19, 2024
4 Insider transaction Jun 20, 2024 Jun 19, 2024
4 Insider transaction Jun 20, 2024 Jun 19, 2024
4 Insider transaction Jun 20, 2024 Jun 19, 2024
144 Notice of proposed sale Jun 20, 2024 —
144 Notice of proposed sale Jun 20, 2024 —
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Jun 17, 2024 Jun 14, 2024
144 Notice of proposed sale Jun 17, 2024 —
PX14A6G Filing Jun 13, 2024 —
PX14A6G Calstrs form px14a6g Jun 10, 2024 —
10-Q Quarterly report May 6, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 1, 2024 May 1, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 29, 2024 —
DEF 14A Proxy statement Apr 29, 2024 Jun 14, 2024
PRE 14A Preliminary proxy statement Apr 18, 2024 Jun 4, 2024
4 Insider transaction Mar 15, 2024 Mar 13, 2024
4 Insider transaction Mar 13, 2024 Mar 12, 2024
144 Notice of proposed sale Mar 13, 2024 —
144 Notice of proposed sale Mar 12, 2024 —
10-K Annual report Feb 29, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 28, 2024 Feb 28, 2024
5 Annual insider ownership Feb 14, 2024 Feb 14, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 26, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 25, 2024 —
8-K Current report
Material agreement, Regulation FD disclosure
Jan 10, 2024 Jan 7, 2024
4 Insider transaction Jan 8, 2024 Jan 5, 2024
4 Insider transaction Jan 8, 2024 Jan 5, 2024
4 Insider transaction Jan 5, 2024 Jan 3, 2024
144 Notice of proposed sale Jan 5, 2024 —
144 Notice of proposed sale Jan 3, 2024 —
10-Q Quarterly report Nov 6, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 1, 2023 Nov 1, 2023
4 Insider transaction Sep 29, 2023 Sep 28, 2023
4 Insider transaction Sep 29, 2023 Sep 28, 2023
4 Insider transaction Sep 29, 2023 Sep 28, 2023
4 Insider transaction Sep 29, 2023 Sep 28, 2023
4 Insider transaction Sep 29, 2023 Sep 28, 2023
4 Insider transaction Aug 14, 2023 Aug 11, 2023
10-Q Quarterly report Aug 4, 2023 Jun 30, 2023
8-K Current report
Material agreement, Results of operations
Aug 1, 2023 Jul 28, 2023
4 Insider transaction Jun 26, 2023 Jun 23, 2023
144 Notice of proposed sale Jun 23, 2023 —
8-K Current report
Shareholder vote results
Jun 15, 2023 Jun 14, 2023
4 Insider transaction Jun 5, 2023 Jun 2, 2023
144 Notice of proposed sale Jun 2, 2023 —
10-Q Quarterly report May 8, 2023 Mar 31, 2023
DEFA14A Additional proxy material May 1, 2023 —
DEF 14A Proxy statement May 1, 2023 —
8-K Current report
Results of operations
May 1, 2023 May 1, 2023
PRE 14A Preliminary proxy statement Apr 21, 2023 —
SC 13G Ownership over 5% (passive) Apr 3, 2023 —
4 Insider transaction Mar 14, 2023 Mar 12, 2023
4 Insider transaction Mar 14, 2023 Mar 12, 2023
10-K Annual report Mar 1, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 28, 2023 Feb 28, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 3, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 1, 2023 —
4 Insider transaction Jan 6, 2023 Jan 6, 2023
4 Insider transaction Jan 6, 2023 Jan 4, 2023
8-K Current report
Other events
Dec 28, 2022 Dec 28, 2022
8-K Current report
Results of operations
Nov 10, 2022 Nov 10, 2022
10-Q Quarterly report Nov 9, 2022 Sep 30, 2022
SC 13G/A Amended ownership over 5% (passive) Oct 11, 2022 —
S-3ASR Automatic shelf registration Sep 2, 2022 —
10-Q Quarterly report Aug 9, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 8, 2022 Aug 8, 2022
4 Insider transaction Jul 22, 2022 Jul 20, 2022
4 Insider transaction Jul 22, 2022 Jul 20, 2022
4 Insider transaction Jul 22, 2022 Jul 20, 2022
4 Insider transaction Jul 22, 2022 Jul 20, 2022
4 Insider transaction Jul 22, 2022 Jul 20, 2022
4 Insider transaction Jul 22, 2022 Jul 20, 2022
4 Insider transaction Jul 22, 2022 Jul 20, 2022
SC 13G/A Amended ownership over 5% (passive) Jul 11, 2022 —
S-8 Employee stock plan registration Jun 24, 2022 —
8-K Current report
Shareholder vote results
Jun 23, 2022 Jun 16, 2022
10-Q Quarterly report May 10, 2022 Mar 31, 2022
DEFA14A Additional proxy material Apr 29, 2022 —
DEF 14A Proxy statement Apr 29, 2022 Jun 16, 2022
8-K Current report
Other events
Apr 18, 2022 Apr 15, 2022
10-K Annual report Mar 1, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 1, 2022 Mar 1, 2022
SC 13G/A Amended ownership over 5% (passive) Feb 10, 2022 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2022 —
SC 13G/A Amended ownership over 5% (passive) Feb 1, 2022 —
8-K Current report
Other events
Jan 27, 2022 Jan 27, 2022
4 Insider transaction Jan 7, 2022 Jan 4, 2022
4 Insider transaction Jan 7, 2022 Dec 29, 2021
8-K Current report
Material agreement
Jan 4, 2022 Dec 30, 2021
8-K Current report
Other events
Nov 30, 2021 Nov 30, 2021
10-Q Quarterly report Nov 8, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 4, 2021 Nov 4, 2021
10-Q Quarterly report Aug 6, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 2, 2021 Aug 2, 2021
8-K Current report
Officer or director change
Jun 23, 2021 Jun 18, 2021
4 Insider transaction Jun 22, 2021 Jun 18, 2021
4 Insider transaction Jun 22, 2021 Jun 18, 2021
4 Insider transaction Jun 22, 2021 Jun 18, 2021
4 Insider transaction Jun 22, 2021 Jun 18, 2021
4 Insider transaction Jun 22, 2021 Jun 18, 2021
4 Insider transaction Jun 22, 2021 Jun 18, 2021
4 Insider transaction Jun 22, 2021 Jun 18, 2021
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 21, 2021 Jun 16, 2021
10-Q Quarterly report May 10, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 10, 2021 May 10, 2021
DEFA14A Additional proxy material Apr 30, 2021 —
DEF 14A Proxy statement Apr 30, 2021 Jun 16, 2021
PRE 14A Preliminary proxy statement Apr 20, 2021 Jun 16, 2021
8-K Current report
Other events
Apr 16, 2021 Apr 16, 2021
8-K Current report
Auditor change
Apr 13, 2021 Apr 12, 2021
8-K Current report
Results of operations
Mar 2, 2021 Mar 2, 2021
10-K Annual report Mar 1, 2021 Dec 31, 2020
SC 13G/A Amended ownership over 5% (passive) Feb 16, 2021 —
5 Annual insider ownership Feb 12, 2021 Dec 31, 2020
SC 13G/A Amended ownership over 5% (passive) Feb 10, 2021 —
SC 13G/A Amended ownership over 5% (passive) Feb 10, 2021 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
TGTX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Large accelerated filer
SEC CIK
1001316
Former names
MANHATTAN PHARMACEUTICALS INC (until Apr 27, 2012); ATLANTIC TECHNOLOGY VENTURES INC (until Mar 10, 2003); ATLANTIC PHARMACEUTICALS INC (until Feb 4, 2000)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.